Symbol: NVO Sector: Healthcare Industry: Biotechnology
| Dividend Yield: | 3.26% | |
| Dividend per Share: | $ 1.5540 | |
| Next Ex-Div Date: | 2019-03-22 | |
| Next Div Payout: | $ 0.7770 | |
| Payment Schedule: | Half Yearly | - |
| Earnings Per Share (ttm) | 2.53 |
| Payout Ratio (ttm) | n.a. |
| Ø 3yr Growth Rate | +20.20 % | +8.08% |
| Ø 5yr Growth Rate | +12.12 % | - |
| Type: | Common Stock |
| Exchange: | New York Stock Exchange |
| Current Price (*): | $ 47.66 |
| Week 52 high: | $ 52.83 |
| Week 52 low: | $ 41.23 |
| Marketcap | $ 121,709,854,852 |
| Return on Equity | 83.71 % |
| P/E Ratio (ttm) | 18.84 |
| P/E Ratio high | 36.90 |
| P/E Ratio low | 15.50 |
About: Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.
Tags: Biotechnology Healthcare
Website: http://www.novonordisk.com